Nanomedicine News

RSS

VivaGel Demonstrates Anti-HIV and Herpes Activity Following Human Administration

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the results of its clinical trial demonstrating that VivaGel® retains antiviral activity against human immunodeficiency virus (HIV) and herpes simple...

3 Aug 2009

Nanoengineers, Biologists and Physicists Use Innovative Approaches to Deduce Internal Structure of Chromatin

A group of nanoengineers, biologists and physicists have used innovative approaches to deduce the internal structure of chromatin, a key player in DNA regulation, to reconcile a longstanding controversy in this field. This new finding could unlock the mystery behind the origin of many diseases such as cancer.

31 Jul 2009

Arrowhead Research Board Members Featured in Nature Medicine and Nature Magazines for Outstanding Work in Nanomedicine

Arrowhead Research Corporation (NASDAQ: ARWR), a nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy, today announced that Scientific Advisory Board members Maur...

From Arrowhead Pharmaceutical 31 Jul 2009

Conference Focuses on Latest Advances in Nanotechnology

Conference will focus on the latest advances in nanostructured materials and systems with applications in biomedicine, chemical synthesis, energy generation and photonics The Institute of Bioengineering and Nanotechn...

30 Jul 2009

RNA Degradation Can Lead to Cancer When Improperly Regulated

Thousands of scientists and hundreds of software programmers studying the process by which RNA inside cells normally degrades may soon broaden their focus significantly. That's because University of Wisconsin-Mad...

30 Jul 2009

Study Suggests Nanomachines that Read our Genes Don't Run as Smoothly as Previously Thought

The body's nanomachines that read our genes don't run as smoothly as previously thought, according to a new study by University of California, Berkeley, scientists.

30 Jul 2009

Nanotechnology Targeting Ovarian Cancer

Tiny particles carrying a killer gene can effectively suppress ovarian tumor growth in mice, according to a team of researchers from MIT and the Lankenau Institute.

30 Jul 2009

Bioo Scientific Receives SBIR Phase II Award from NSF to Develop a Targeted in Vivo RNAi Delivery Technology

Bioo Scientific, an Austin, TX based biotechnology company, announced today that it has been awarded a $500,000 Small Business Innovation Research (SBIR) Phase II grant from the National Science Foundation for the development of a targeted in vivo RNA Interference (RNAi) delivery technology.

30 Jul 2009

Treating Advanced Ovarian Cancer with Nanotechnology

Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.

30 Jul 2009

Novel Approach Offers Insight into Protein Structure

John Spence, a physicist at Arizona State University, is a longtime user of the Advanced Light Source at Lawrence Berkeley National Laboratory, where he has contributed to major advances in lensless imaging. It's a particularly apt propensity for someone who works with x-rays, since they can't be focused with ordinary lenses.

From Lawrence Berkeley National Laboratory 29 Jul 2009